APA (7th ed.) Citation

Einsele, H., Moreau, P., Bahlis, N., Bhutani, M., Vincent, L., Karlin, L., . . . Mateos, M. (2024). Comparative efficacy of talquetamab vs. current treatments in the LocoMMotion and MoMMent studies in patients with triple-class-exposed relapsed/refractory multiple myeloma. Advances in therapy, 41(4), . https://doi.org/10.1007/s12325-024-02797-x

Chicago Style (17th ed.) Citation

Einsele, Hermann, et al. "Comparative Efficacy of Talquetamab Vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-class-exposed Relapsed/refractory Multiple Myeloma." Advances in Therapy 41, no. 4 (2024). https://doi.org/10.1007/s12325-024-02797-x.

MLA (9th ed.) Citation

Einsele, Hermann, et al. "Comparative Efficacy of Talquetamab Vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-class-exposed Relapsed/refractory Multiple Myeloma." Advances in Therapy, vol. 41, no. 4, 2024, https://doi.org/10.1007/s12325-024-02797-x.